|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Number of the document | 3169361 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15747647.4 |
| Date of filing the European patent application | 2015-07-15 | |
| (97) | Date of publication of the European application | 2017-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/040582 |
| Date | 2015-07-15 |
| (87) | Number | WO 2016/011160 |
| Date | 2016-01-21 |
| (30) | Number | Date | Country code |
| 201462024988 P | 2014-07-15 | US |
| (72) |
JUNTTILA, Melissa, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS |
| COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS |